Indonesia to Host First Dual-Species Malaria Vaccination Trial

OUCRU Indonesia is preparing a Phase 2 clinical trial of a malaria vaccination designed to protect against the two most widespread malaria parasites, Plasmodium falciparum and Plasmodium vivax. The trial, to be conducted in Keerom, Papua, will be the first to test a dual-species malaria vaccination in humans.  The trial will test two vaccines developed […]

Wellcome Trust Delegates Visit OUCRU Indonesia

On 14 October 2024, a delegation from Wellcome visited OUCRU Indonesia to deepen their understanding of the unit’s research, learn about its collaborations with various partners, and gain insights into its capacity-building initiatives for local researchers.  The visit began with a meeting between the Wellcome delegates and key members of the Faculty of Medicine Universitas […]

OUCRU and Universitas Indonesia Complete Historic Malaria Vaccine Trial

In a major achievement, the Faculty of Medicine Universitas Indonesia (FMUI) and OUCRU Indonesia have completed a phase 2 clinical trial for two new malaria vaccines developed by Sanaria Inc. This is the first malaria vaccine trial ever conducted in Indonesia and the first in the Asia-Pacific region in over 30 years. Groundbreaking Research in […]

Skip to content